![Paul Moore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Moore
Directeur Technique/Scientifique/R&D chez
ZYMEWORKS INC.
Fortune : 1 M $ au 31/08/2026
Profil
Paul A. Moore is Chief Scientific Officer at Zymeworks BC, Inc. and Zymeworks, Inc., both positions starting in 2022.
Former roles include Director-Lead Product Development at Human Genome Sciences, Inc., Director-Cell Biology at Celera Corp.
from 2005 to 2008, and Vice President-Cell Biology & Immunology at MacroGenics, Inc. from 2008 to 2022.
Education includes a doctorate from the University of Glasgow and an undergraduate degree from the University of Strathclyde.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZYMEWORKS INC. 0,07 % | 12/01/2026 | 48 497 ( 0,07 % ) | 1 M $ | 31/08/2026 |
Postes actifs de Paul Moore
| Sociétés | Poste | Début |
|---|---|---|
| ZYMEWORKS INC. | Directeur Technique/Scientifique/R&D | 01/07/2022 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Directeur Technique/Scientifique/R&D | 18/07/2022 |
Anciens postes connus de Paul Moore
| Sociétés | Poste | Fin |
|---|---|---|
| MACROGENICS, INC. | Corporate Officer/Principal | 01/07/2022 |
Celera Corp.
 Celera Corp. Medical/Nursing ServicesHealth Services Provides medical diagnostic services | Corporate Officer/Principal | 01/04/2008 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | - |
Formation de Paul Moore
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
Celera Corp.
Celera Corp. Medical/Nursing ServicesHealth Services Provides medical diagnostic services | Health Services |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
